Showing results (271-280 of 396) with videos related to

Sort By:
Pageof 40
Annals of Hematology|October 1, 1996
Response to cytarabine ocfosfate (YNK01) in a patient with chronic lymphocytic leukemia refractory to treatment with chlorambucil/prednisone, fludarabine, and prednimustine/mitoxantroneJ Braess, W Kern, M Unterhalt, et al.
Haematology and Blood Transfusion|January 1, 1987
Postinduction and preremission chemotherapy alternatives for adult AML: three multicenter studies of the AML Cooperative GroupT Büchner, W Hiddemann, D Urbanitz, et al.
Leukemia|November 1, 1992
Combined effect of very early intensification and prolonged post-remission chemotherapy in patients with AMLT Büchner, W Hiddemann, U W Schaefer, et al.
Hematological Oncology|March 1, 1993
Subcutaneous low dose arabinosyl-cytosine and oral idarubicin in high risk adult acute myelogenous leukemiaC R Kusnierz-Glaz, D Normann, R Weinberg, et al.
Cancer|February 1, 1992
Treatment of relapsed or refractory adult acute lymphocytic leukemiaM Freund, H Diedrich, A Ganser, et al.
Leukemia|October 10, 1998
Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomasC Pott, M Tiemann, B Linke, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Accidental overdose of mitoxantrone in three patientsW Siegert, W Hiddemann, R Koppensteiner, et al.
Blood|March 1, 1987
High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemiaW Hiddemann, H Kreutzmann, K Straif, et al.
Onkologie|June 1, 1985
Immunotherapy with allogeneic neuraminidase-treated blasts for maintenance in acute myelogenous leukemia (AML). Significant prolongation of remission duration in patients receiving at least 3 cycles of therapyD Urbanitz, H J Pielken, P Koch, et al.
International Journal of Hematology|October 7, 2008
AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicityL H Lindner, H Ostermann, W Hiddemann, et al.
Pageof 40